0000000000121728

AUTHOR

Marcos Antonio Lloret-durà

showing 3 related works from this author

Factors related to early castration resistance in metastatic prostate cancer. Results from the National Prostate Cancer Registry in Spain

2019

Abstract Introduction The objective of the study was to determine the factors independently related with the development of castration resistance (CR) in prostate cancer (PC) in the medium term. Material and methods 155 patients diagnosed with metastatic PC with a follow-up of up to 39 months. Data taken from the National PC Registry. The evaluated variables were age, PSA, nadir PSA, Gleason, perineural invasion, TNM stages, and ADT type (intermittent / continuous). Results Mean follow-up 26,2 ± 13,4 months. 47.1% developed early CR, with mean time until onset of 12,2 ± 8,7 months. Univariate analysis: the mean PSA was correlated with CR (290 ± 905,1 ng/mL in non CR, 519,1 ± 1437,2 ng/mL in…

Oncologymedicine.medical_specialtyUnivariate analysisMultivariate analysisbusiness.industry030232 urology & nephrologyPerineural invasionGeneral Medicinemedicine.diseaseLower risk03 medical and health sciencesProstate cancer0302 clinical medicineCastration ResistanceInternal medicineTumor stagemedicinebusinessNadir (topography)Actas Urológicas Españolas (English Edition)
researchProduct

Factores relacionados con la resistencia a la castración precoz en el cáncer de próstata metastásico. Resultados del Registro nacional de cáncer de p…

2019

Resumen Introduccion El objetivo del estudio fue establecer los factores que se relacionan de forma independiente con el desarrollo de resistencia a la castracion (RC) a medio plazo en el cancer de prostata (CP). Material y metodos Ciento cincuenta y cinco pacientes con CP metastasicos al diagnostico del registro nacional de CP con un seguimiento de hasta 39 meses. Las variables estudiadas fueron: edad, PSA, nadir de PSA, Gleason, invasion perineural, estadios T, N y M y tipo de bloqueo (intermitente/continuo). Resultados Media de seguimiento 26,2 ± 13,4 meses. El 47,1% desarrollo RC precoz, con una media hasta el desarrollo de RC 12,2 ± 8,7 meses. Analisis univariante: se relacionaron con …

Gynecology03 medical and health sciencesmedicine.medical_specialty0302 clinical medicinebusiness.industryUrology030232 urology & nephrologymedicinebusinessActas Urológicas Españolas
researchProduct

Ureteral realignment with combined access as a treatment of complete ureteral transection.

2019

Ureteral realignment using a ureteral stent can be an alternative treatment in cases of complete ureteral transection and may avoid the need for reconstructive surgery. The combined access can help the passage of the guidewire through the injured area and the threading of the urinary system of the patient. We present a case of a 38-year-old man with multiples abdominal surgeries, who underwent a complete ureteral section treated with ureteral realignment with combined access. The subsequent evolution was favourable, with resolution of the ureteral injury at the acute time, and without the presence of long-term obstruction. Although we must accept that the standard treatment of the complete …

AdultMalemedicine.medical_specialtyReconstructive surgeryUrologyUrinary systemmedicine.medical_treatmentAnastomosisUreteral realignmenturologic and male genital diseaseslcsh:RC870-923Ureteral injurymedicineHumansbusiness.industryurogenital systemStandard treatmentTreatment optionsStentlcsh:Diseases of the genitourinary system. UrologyAlternative treatmentfemale genital diseases and pregnancy complicationsSurgeryUreteral traumasurgical procedures operativeUrologic Surgical ProceduresUreterbusinessEndourologyUreteral transectionArchivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica
researchProduct